Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

11.02
Delayed Data
As of Dec 02
 -0.11 / -0.99%
Today’s Change
10.01
Today|||52-Week Range
33.88
-61.51%
Year-to-Date
The Worst Marijuana Stocks in 2016
Dec 02 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: American Electric Power, Amgen, Dow Chemical
Nov 30 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close11.13
Today’s open11.09
Day’s range10.91 - 11.32
Volume564,738
Average volume (3 months)736,831
Market cap$790.9M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-74.82%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.92%
P/E ratio35.5
Price/Sales6.55
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc0.000.00%
FOLDAmicus Therapeutics ...0.000.00%
ZIOPZIOPHARM Oncology In...+0.16+2.55%
FWPForward Pharma A/S-0.44-2.45%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John N. Kapoor
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts


Search for Jobs